| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/15/2010 | DE102009004959A1 Use of at least one transaminase inhibitor for producing an agent for the prophylaxis and treatment of pityriasis versicolor |
| 07/15/2010 | CA2749143A1 Compositions for enhancing nail growth |
| 07/15/2010 | CA2749141A1 Cyclosporine compositions for enhancing nail growth |
| 07/15/2010 | CA2747611A1 Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces |
| 07/15/2010 | CA2746508A1 Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis |
| 07/14/2010 | EP2206772A2 Method of collecting placental stem cells |
| 07/14/2010 | EP2206720A1 Albumin fusion proteins |
| 07/14/2010 | EP2206714A1 Agent for prevention and/or treatment of skin diseases |
| 07/14/2010 | EP2206511A1 Protein a compositions and methods of use |
| 07/14/2010 | EP2205620A2 An amorphous form of an anti-inflammatory compound |
| 07/14/2010 | EP2205254A1 Method of producing plant extract formulations |
| 07/14/2010 | EP2205237A1 Methods for protecting the skin from radiation insults |
| 07/14/2010 | EP2205236A2 Novel agents for treatment of ailments and dysfunctions |
| 07/14/2010 | EP2205228A2 Patch for cutaneous application, which comprises a hydrophile powder |
| 07/14/2010 | EP1486494B1 N-substituted benzothiophenesulfonamide derivative |
| 07/14/2010 | EP1440148B1 Keratinocytes which may be used as biologically active substances for the treatment of wounds |
| 07/14/2010 | EP1200100B1 Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration |
| 07/14/2010 | CN101778619A Gel-like composition for external application comprising adenine compound |
| 07/14/2010 | CN101773669A HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 07/14/2010 | CN101773662A Water soluble gel for treating burn and scald |
| 07/14/2010 | CN101773629A External application Chinese medicine for treating beriberi |
| 07/14/2010 | CN101773621A Chinese medicine for treating spontaneous sweating and preparation method thereof |
| 07/14/2010 | CN101773588A Artemisinin compound suppository for treating female genital diseases and preparation method thereof |
| 07/14/2010 | CN101773543A Chinese medicine preparation for treating beriberi and preparation method thereof |
| 07/14/2010 | CN101773541A Yupingfeng soft capsule |
| 07/14/2010 | CN101773520A Compound antimicrobial containing polyvalent silver ions and preparation method thereof |
| 07/14/2010 | CN101773518A Medicine for treating infectious diseases |
| 07/14/2010 | CN101773511A Compound topical combination drug for treatment of acne and preparation method thereof |
| 07/14/2010 | CN101773464A Nano whitening anti-wrinkle speckle-removing blain-removing formula and production method thereof |
| 07/14/2010 | CN101274045B Exterior-applied medicament for treating psoriasis |
| 07/14/2010 | CN101229188B External medicine for onychomycosis |
| 07/14/2010 | CN101199652B Medicament for treating acute, subacute eczema and preparing method thereof |
| 07/14/2010 | CN101138556B Terbinafine or its salt film forming gel composition and uses thereof |
| 07/14/2010 | CN101077881B 1-O-beta-D-glucopyranosylgeraniol-10,5-olide and use thereof |
| 07/14/2010 | CN101077362B Plant-type skin mucosa disinfecting agent |
| 07/13/2010 | US7754864 Tyrosinase activity controlling agent, process for producing the same and external preparation containing the same |
| 07/13/2010 | US7754774 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
| 07/13/2010 | US7754772 (2R)-2,3-bis(nitrooxy)propyl(2S)-2(6-methoxy(2-naphthyl)propanoate, used for treating inflammation, pain and fever; gastrointestinal disorders; wound healing agents; preventing gastrointestinal, renal and/or respiratory toxicities; side effect reduction |
| 07/13/2010 | US7754750 a -5 substituted 1-H,3-H-imidazolidine-2,4-dione such as 5-(2-{[4-(4'-fluoro[1,1'-biphenyl]-4-yl)-1-piperazinyl]sulfonyl}ethyl)-2,4-imidazolidinedione; protease inhibitors, especially metalloelastase (MMP12) |
| 07/13/2010 | US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2) |
| 07/13/2010 | US7754728 Adenine compound and use thereof |
| 07/13/2010 | US7754481 Using cultured keratin synthesizing cells as therapeutic tools in treatment of chronic injury; regenerative medicine; tissue engineering |
| 07/13/2010 | US7754240 Solid at ambient temperature, softening point of </= 35 degrees C., when placed in continuous contact with skin it is softened to a consistency so substantial application of the unit dose is delivered in < 10 minutes |
| 07/13/2010 | US7754217 HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 07/13/2010 | CA2557536C Amino alcohol compound |
| 07/13/2010 | CA2505910C Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 07/13/2010 | CA2448303C Biologically active methylene blue derivatives |
| 07/13/2010 | CA2446820C Novel pyrrole derivatives as pharmaceutical agents |
| 07/13/2010 | CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 07/13/2010 | CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 07/13/2010 | CA2414239C Analgesic anti-inflammatory patch for topical application |
| 07/08/2010 | WO2010078580A2 Immunotherapy for contact dermatitis using co-signal regulation |
| 07/08/2010 | WO2010077971A2 Acne treatment powder foundation |
| 07/08/2010 | WO2010077101A2 Novel thiazolidinedione derivative and use thereof |
| 07/08/2010 | WO2010077093A2 Composition for promoting hair growth or preventing hair loss comprising erythropoietin |
| 07/08/2010 | WO2010076879A1 Sulfated c-glycoside, method for isolating same and method for synthesizing same |
| 07/08/2010 | WO2010076803A2 Topical systems and kits |
| 07/08/2010 | WO2010052568A8 Method for the preparation of medical devices and devices obtained therefrom |
| 07/08/2010 | WO2010049485A3 Topical formulation of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate |
| 07/08/2010 | WO2010049144A3 Ligands for modulation of orphan receptor-gamma (nr1f3 ) activity |
| 07/08/2010 | WO2010039742A3 Methods to reduce b-helper t cells to treat autoimmune diseases |
| 07/08/2010 | WO2010034011A3 Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release |
| 07/08/2010 | WO2010028254A3 Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases |
| 07/08/2010 | WO2010027189A3 A new use for homoisoflavanone or a salt thereof |
| 07/08/2010 | US20100174222 Method and apparatus for acne treatment using low intensity light therapy |
| 07/08/2010 | US20100174076 Coumarin derivatives useful as tnf alpha inhibitors |
| 07/08/2010 | US20100174000 Carrier in the form of oil-in-water emulsion notably intended for ophthalmic or dermocosmetic use |
| 07/08/2010 | US20100173995 Use of PPAR-alpha activator as inflammatory skin disease-treating agent and method for treating skin diseases using the same |
| 07/08/2010 | US20100173967 Use of spiro-oxindole compounds as therapeutic agents |
| 07/08/2010 | US20100173955 4-substituted phenoxyphenylacetic acid derivatives |
| 07/08/2010 | US20100173901 Substituted Heterocyclic Compounds |
| 07/08/2010 | US20100173889 Substituted Pyrimidine and Triazine Compounds |
| 07/08/2010 | US20100173881 Compositions for the treatment of inflammatory disorders |
| 07/08/2010 | US20100173876 Oil-based nsaid compositions and methods for making and using same |
| 07/08/2010 | US20100173868 Composition and method for healing tissues |
| 07/08/2010 | US20100173857 Spinosyns For Wound Healing |
| 07/08/2010 | US20100173855 Dermatological Formulations |
| 07/08/2010 | US20100173848 Methods of inhibiting chemokine binding to chemokines receptors |
| 07/08/2010 | US20100173843 Tissue adhering compositions |
| 07/08/2010 | US20100173413 Pyridine compounds |
| 07/08/2010 | US20100173027 O/w emulsion for hand care |
| 07/08/2010 | US20100173024 Methods and compositions for altering health, wellbeing, and lifespan |
| 07/08/2010 | US20100173023 Ginseng Radix, Astragali Radix, Batatatis Rhizoma, Zizyphi Fructus, Tremella, Codonopsis Pilosula, Angelicae Radix, Rehmanniae Preparata Radix, Longanae Arillus, Lycii Fructus, Paeonia lactiflora, Rehmanniae Radix, Ligustrum Lucidum, and Eclipta prostrata; spray drying, freeze drying |
| 07/08/2010 | US20100173021 Topical Product formulations containing strontium for reducing skin irritation |
| 07/08/2010 | US20100173017 Method of manufacturing skin care cream containing baked shell powder |
| 07/08/2010 | US20100172993 Particles for delivery of active ingredients, process of making and compositions thereof |
| 07/08/2010 | US20100172992 Pathogenic attenuation via the administration of an equilibiotic compound |
| 07/08/2010 | US20100172975 Treatment of hyperproliferative disorders with diarylhydantoin compounds |
| 07/08/2010 | US20100172964 Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle |
| 07/08/2010 | US20100172960 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |
| 07/08/2010 | US20100172958 Wound dressing devices and methods |
| 07/08/2010 | US20100172957 Eflucimibe medicaments for preventing/treating a disease due to sebaceous gland dysfunction in humans or animals |
| 07/08/2010 | US20100172943 Peptide nanoparticles and uses therefor |
| 07/08/2010 | US20100172912 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 07/08/2010 | US20100172911 Methods and Vectors for Generating Asialylated Immunoglobulins |
| 07/08/2010 | US20100172904 Mcp1 fusions |
| 07/08/2010 | US20100172896 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 07/08/2010 | US20100172892 Hyaluronidase and method of use thereof |
| 07/08/2010 | US20100172886 Method for Promoting Wound Healing |
| 07/08/2010 | US20100172885 Multipotent Adult Stem Cells And Uses of Multipotent Adult Stem Cells To Treat Inflammation |